STANDARD BIOTOOLS INC. — Director's Dealing 2023

Feb 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-02-21

Reporting Person: JOG VIKRAM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-21	Common Stock	M	50000	—	Acquired	221904	Direct
2023-02-21	Common Stock	M	16666	—	Acquired	238570	Direct
2023-02-21	Common Stock	M	2238	—	Acquired	240808	Direct
2023-02-21	Common Stock	M	2391	—	Acquired	243199	Direct
2023-02-21	Common Stock	M	3130	—	Acquired	246329	Direct
2023-02-21	Common Stock	F	28707	$2.03	Disposed	217622	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-21	Restricted Stock Units	$	M	50000	Disposed		Common Stock (50000.0)	Direct
2023-02-21	Restricted Stock Units	$	M	16666	Disposed		Common Stock (16666.0)	Direct
2023-02-21	Restricted Stock Units	$	M	2238	Disposed		Common Stock (2238.0)	Direct
2023-02-21	Restricted Stock Units	$	M	2391	Disposed		Common Stock (2391.0)	Direct
2023-02-21	Restricted Stock Units	$	A	3130	Disposed		Common Stock (3130.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	52061	Indirect

Footnotes

F1: Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F3: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."

F4: On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.

F5: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F6: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F7: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.